A cross-sectional study of MRI features and the gut microbiome in pediatric-onset multiple sclerosis

Feng Zhu1, Yinshan Zhao1, Douglas L Arnold2

  • 1Department of Medicine (Neurology), The University of British Columbia, Vancouver, British Columbia, Canada.

Insights

Gut bacteria like Tenericutes correlate with higher MRI lesion volume in pediatric multiple sclerosis (MS). Conversely, Firmicutes and other bacteria are linked to lower lesion burden in pediatric MS patients.

Area of Science:

  • Microbiome research
  • Neuroimmunology
  • Pediatric neurology

Background:

  • Pediatric-onset multiple sclerosis (MS) is a debilitating autoimmune disease affecting young individuals.
  • The gut microbiome's role in neuroinflammation and MS pathogenesis is increasingly recognized.
  • Understanding gut microbiome associations with disease markers like MRI lesion burden is crucial for pediatric MS.

Purpose of the Study:

  • To investigate the relationship between gut microbiome composition and MRI-assessed lesion burden in pediatric-onset MS.
  • To identify specific bacterial taxa (phyla and genera) associated with lesion volume in this population.

Main Methods:

  • Cross-sectional study of pediatric-onset MS participants from the Canadian Paediatric Demyelinating Disease Network.
  • 16S rRNA sequencing of stool samples to analyze gut microbiome features (diversity, taxa abundance).
  • Brain MRI (T1 and T2 lesion volumes) acquired within 6 months of stool collection; statistical analysis using regression models.

Main Results:

  • No significant association found between gut microbial alpha diversity and lesion volumes.
  • Higher relative abundance of Tenericutes was associated with increased T1 and T2 lesion volumes.
  • Increased lesion volumes were linked to higher Ruminiclostridium and lower Coprococcus 3 and Erysipelatoclostridium at the genus level.

Conclusions:

  • Specific gut bacterial phyla and genera are associated with MRI lesion burden in pediatric-onset MS.
  • These findings suggest a potential role for the gut microbiota in the pathophysiology of pediatric MS.
  • Further research into gut microbiome modulation could offer novel therapeutic strategies for pediatric MS.
Abstract